ANKTIVA vs TECENTRIQ

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. ANKTIVA and TECENTRIQ are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	ANKTIVA	TECENTRIQ
Rating	New	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	nogapendekin alfa inbakicept-pmln	ATEZOLIZUMAB
Manufacturer	Altor Bioscience, LLC, An Indirect Wholly-Owned Su	Genentech Inc
Dosage forms	Solution	Injectable
Drug class	Interleukin-15 Receptor Agonist	—
Boxed warning	None	None
Treats	Urinary Bladder Neoplasms	Urinary Bladder Neoplasms, Non-Small-Cell Lung Carcinoma, Hepatocellular Carcinoma

anktiva tecentriq

Rating

New

70/100

Pharmacy pays

—

Type

Active ingredient

nogapendekin alfa inbakicept-pmln

ATEZOLIZUMAB

Manufacturer

Altor Bioscience, LLC, An Indirect Wholly-Owned Su

Genentech Inc

Dosage forms

Solution

Injectable

Drug class

Interleukin-15 Receptor Agonist

—

Boxed warning

None

Treats

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms, Non-Small-Cell Lung Carcinoma, Hepatocellular Carcinoma

Frequently asked questions

What is the difference between Anktiva and Tecentriq?

Anktiva contains Nogapendekin Alfa Inbakicept-Pmln, while Tecentriq contains Atezolizumab — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.